Industry Research Reports
Home > Reports > Pharma & Healthcare > Octreotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Octreotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Pharma & Healthcare
Published Date: 2025-01-16
Pages: 103 Pages
Report ld: 3473853
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Octreotide Market Size(US$)
CAGR 2025-2031
-2.8%
Market Size,2031
USD 2.3
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 2.8 million
Market Forecast in 2031(Value)
US$ 2.3 million
CAGR
-2.8%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Octreotide was estimated to be worth US$ 2.8 million in 2024 and is forecast to a readjusted size of US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Global Octreotide key players include Novartis, SUN, Tiantaishan pharmaceutical, Sinopharm A-Think, Sihuan Pharmaceutical, etc. Global top five manufacturers hold a share over 90%.
Europe is the largest market, with a share over 65%, followed by India and China, both have a share over 30%.
This report aims to provide a comprehensive presentation of the global market for Octreotide, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Octreotide by region & country, by Type, and by Application.
The Octreotide market size, estimations, and forecasts are provided in terms of sales volume (Gram) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Octreotide.
MARKET SEGMENTATION
By Company
- Novartis
- Sun Pharmaceutical
- Chengdu Tiantaishan pharmaceutical
- Sinopharm A-Think Pharmaceuticals
- Sihuan Pharmaceutical Holdings Group
- Shanghai Soho-Yiming Pharmaceuticals
- Yibin Pharmaceutical
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Octreotide Injection
- Octreotide Powder
- Octreotide Microspheres
Segment by Application
- Treating Severe Diarrhea
- Treating Acromegaly
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Octreotide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Octreotide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Octreotide in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Octreotide Product Introduction
1.2 Global Octreotide Market Size Forecast
1.2.1 Global Octreotide Sales Value (2020-2031)
1.2.2 Global Octreotide Sales Volume (2020-2031)
1.2.3 Global Octreotide Sales Price (2020-2031)
1.3 Octreotide Market Trends & Drivers
1.3.1 Octreotide Industry Trends
1.3.2 Octreotide Market Drivers & Opportunity
1.3.3 Octreotide Market Challenges
1.3.4 Octreotide Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Octreotide Players Revenue Ranking (2024)
2.2 Global Octreotide Revenue by Company (2020-2025)
2.3 Global Octreotide Players Sales Volume Ranking (2024)
2.4 Global Octreotide Sales Volume by Company Players (2020-2025)
2.5 Global Octreotide Average Price by Company (2020-2025)
2.6 Key Manufacturers Octreotide Manufacturing Base and Headquarters
2.7 Key Manufacturers Octreotide Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Octreotide
2.9 Octreotide Market Competitive Analysis
2.9.1 Octreotide Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Octreotide Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Octreotide as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Octreotide Injection
3.1.2 Octreotide Powder
3.1.3 Octreotide Microspheres
3.2 Global Octreotide Sales Value by Type
3.2.1 Global Octreotide Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Octreotide Sales Value, by Type (2020-2031)
3.2.3 Global Octreotide Sales Value, by Type (%) (2020-2031)
3.3 Global Octreotide Sales Volume by Type
3.3.1 Global Octreotide Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Octreotide Sales Volume, by Type (2020-2031)
3.3.3 Global Octreotide Sales Volume, by Type (%) (2020-2031)
3.4 Global Octreotide Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Treating Severe Diarrhea
4.1.2 Treating Acromegaly
4.1.3 Others
4.2 Global Octreotide Sales Value by Application
4.2.1 Global Octreotide Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Octreotide Sales Value, by Application (2020-2031)
4.2.3 Global Octreotide Sales Value, by Application (%) (2020-2031)
4.3 Global Octreotide Sales Volume by Application
4.3.1 Global Octreotide Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Octreotide Sales Volume, by Application (2020-2031)
4.3.3 Global Octreotide Sales Volume, by Application (%) (2020-2031)
4.4 Global Octreotide Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Octreotide Sales Value by Region
5.1.1 Global Octreotide Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Octreotide Sales Value by Region (2020-2025)
5.1.3 Global Octreotide Sales Value by Region (2026-2031)
5.1.4 Global Octreotide Sales Value by Region (%), (2020-2031)
5.2 Global Octreotide Sales Volume by Region
5.2.1 Global Octreotide Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Octreotide Sales Volume by Region (2020-2025)
5.2.3 Global Octreotide Sales Volume by Region (2026-2031)
5.2.4 Global Octreotide Sales Volume by Region (%), (2020-2031)
5.3 Global Octreotide Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Octreotide Sales Value, 2020-2031
5.4.2 North America Octreotide Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Octreotide Sales Value, 2020-2031
5.5.2 Europe Octreotide Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Octreotide Sales Value, 2020-2031
5.6.2 Asia Pacific Octreotide Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Octreotide Sales Value, 2020-2031
5.7.2 South America Octreotide Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Octreotide Sales Value, 2020-2031
5.8.2 Middle East & Africa Octreotide Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Octreotide Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Octreotide Sales Value
6.2.1 Key Countries/Regions Octreotide Sales Value, 2020-2031
6.2.2 Key Countries/Regions Octreotide Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Octreotide Sales Value, 2020-2031
6.3.2 United States Octreotide Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Octreotide Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Octreotide Sales Value, 2020-2031
6.4.2 Europe Octreotide Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Octreotide Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Octreotide Sales Value, 2020-2031
6.5.2 China Octreotide Sales Value by Type (%), 2024 VS 2031
6.5.3 China Octreotide Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Octreotide Sales Value, 2020-2031
6.6.2 Japan Octreotide Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Octreotide Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Octreotide Sales Value, 2020-2031
6.7.2 South Korea Octreotide Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Octreotide Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Octreotide Sales Value, 2020-2031
6.8.2 Southeast Asia Octreotide Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Octreotide Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Octreotide Sales Value, 2020-2031
6.9.2 India Octreotide Sales Value by Type (%), 2024 VS 2031
6.9.3 India Octreotide Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Novartis
7.1.1 Novartis Company Information
7.1.2 Novartis Introduction and Business Overview
7.1.3 Novartis Octreotide Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Novartis Octreotide Product Offerings
7.1.5 Novartis Recent Development
7.2 Sun Pharmaceutical
7.2.1 Sun Pharmaceutical Company Information
7.2.2 Sun Pharmaceutical Introduction and Business Overview
7.2.3 Sun Pharmaceutical Octreotide Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Sun Pharmaceutical Octreotide Product Offerings
7.2.5 Sun Pharmaceutical Recent Development
7.3 Chengdu Tiantaishan pharmaceutical
7.3.1 Chengdu Tiantaishan pharmaceutical Company Information
7.3.2 Chengdu Tiantaishan pharmaceutical Introduction and Business Overview
7.3.3 Chengdu Tiantaishan pharmaceutical Octreotide Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Chengdu Tiantaishan pharmaceutical Octreotide Product Offerings
7.3.5 Chengdu Tiantaishan pharmaceutical Recent Development
7.4 Sinopharm A-Think Pharmaceuticals
7.4.1 Sinopharm A-Think Pharmaceuticals Company Information
7.4.2 Sinopharm A-Think Pharmaceuticals Introduction and Business Overview
7.4.3 Sinopharm A-Think Pharmaceuticals Octreotide Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Sinopharm A-Think Pharmaceuticals Octreotide Product Offerings
7.4.5 Sinopharm A-Think Pharmaceuticals Recent Development
7.5 Sihuan Pharmaceutical Holdings Group
7.5.1 Sihuan Pharmaceutical Holdings Group Company Information
7.5.2 Sihuan Pharmaceutical Holdings Group Introduction and Business Overview
7.5.3 Sihuan Pharmaceutical Holdings Group Octreotide Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Sihuan Pharmaceutical Holdings Group Octreotide Product Offerings
7.5.5 Sihuan Pharmaceutical Holdings Group Recent Development
7.6 Shanghai Soho-Yiming Pharmaceuticals
7.6.1 Shanghai Soho-Yiming Pharmaceuticals Company Information
7.6.2 Shanghai Soho-Yiming Pharmaceuticals Introduction and Business Overview
7.6.3 Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Shanghai Soho-Yiming Pharmaceuticals Octreotide Product Offerings
7.6.5 Shanghai Soho-Yiming Pharmaceuticals Recent Development
7.7 Yibin Pharmaceutical
7.7.1 Yibin Pharmaceutical Company Information
7.7.2 Yibin Pharmaceutical Introduction and Business Overview
7.7.3 Yibin Pharmaceutical Octreotide Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Yibin Pharmaceutical Octreotide Product Offerings
7.7.5 Yibin Pharmaceutical Recent Development
8 Industry Chain Analysis
8.1 Octreotide Industrial Chain
8.2 Octreotide Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Octreotide Sales Model
8.5.2 Sales Channel
8.5.3 Octreotide Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Octreotide Market Trends
Table 2. Octreotide Market Drivers & Opportunity
Table 3. Octreotide Market Challenges
Table 4. Octreotide Market Restraints
Table 5. Global Octreotide Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Octreotide Revenue Market Share by Company (2020-2025)
Table 7. Global Octreotide Sales Volume by Company (2020-2025) & (Gram)
Table 8. Global Octreotide Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Octreotide Price by Company (2020-2025) & (USD/Gram)
Table 10. Key Manufacturers Octreotide Manufacturing Base and Headquarters
Table 11. Key Manufacturers Octreotide Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Octreotide
Table 13. Global Octreotide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Octreotide as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Octreotide Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Octreotide Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Octreotide Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Octreotide Sales Market Share in Value by Type (2020-2025)
Table 20. Global Octreotide Sales Market Share in Value by Type (2026-2031)
Table 21. Global Octreotide Sales Volume by Type: 2020 VS 2024 VS 2031 (Gram)
Table 22. Global Octreotide Sales Volume by Type (2020-2025) & (Gram)
Table 23. Global Octreotide Sales Volume by Type (2026-2031) & (Gram)
Table 24. Global Octreotide Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Octreotide Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Octreotide Price by Type (2020-2025) & (USD/Gram)
Table 27. Global Octreotide Price by Type (2026-2031) & (USD/Gram)
Table 28. Global Octreotide Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Octreotide Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Octreotide Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Octreotide Sales Market Share in Value by Application (2020-2025)
Table 32. Global Octreotide Sales Market Share in Value by Application (2026-2031)
Table 33. Global Octreotide Sales Volume by Application: 2020 VS 2024 VS 2031 (Gram)
Table 34. Global Octreotide Sales Volume by Application (2020-2025) & (Gram)
Table 35. Global Octreotide Sales Volume by Application (2026-2031) & (Gram)
Table 36. Global Octreotide Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Octreotide Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Octreotide Price by Application (2020-2025) & (USD/Gram)
Table 39. Global Octreotide Price by Application (2026-2031) & (USD/Gram)
Table 40. Global Octreotide Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Octreotide Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Octreotide Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Octreotide Sales Value by Region (2020-2025) & (%)
Table 44. Global Octreotide Sales Value by Region (2026-2031) & (%)
Table 45. Global Octreotide Sales Volume by Region (Gram): 2020 VS 2024 VS 2031
Table 46. Global Octreotide Sales Volume by Region (2020-2025) & (Gram)
Table 47. Global Octreotide Sales Volume by Region (2026-2031) & (Gram)
Table 48. Global Octreotide Sales Volume by Region (2020-2025) & (%)
Table 49. Global Octreotide Sales Volume by Region (2026-2031) & (%)
Table 50. Global Octreotide Average Price by Region (2020-2025) & (USD/Gram)
Table 51. Global Octreotide Average Price by Region (2026-2031) & (USD/Gram)
Table 52. Key Countries/Regions Octreotide Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Octreotide Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Octreotide Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Octreotide Sales Volume, (2020-2025) & (Gram)
Table 56. Key Countries/Regions Octreotide Sales Volume, (2026-2031) & (Gram)
Table 57. Novartis Company Information
Table 58. Novartis Introduction and Business Overview
Table 59. Novartis Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 60. Novartis Octreotide Product Offerings
Table 61. Novartis Recent Development
Table 62. Sun Pharmaceutical Company Information
Table 63. Sun Pharmaceutical Introduction and Business Overview
Table 64. Sun Pharmaceutical Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 65. Sun Pharmaceutical Octreotide Product Offerings
Table 66. Sun Pharmaceutical Recent Development
Table 67. Chengdu Tiantaishan pharmaceutical Company Information
Table 68. Chengdu Tiantaishan pharmaceutical Introduction and Business Overview
Table 69. Chengdu Tiantaishan pharmaceutical Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 70. Chengdu Tiantaishan pharmaceutical Octreotide Product Offerings
Table 71. Chengdu Tiantaishan pharmaceutical Recent Development
Table 72. Sinopharm A-Think Pharmaceuticals Company Information
Table 73. Sinopharm A-Think Pharmaceuticals Introduction and Business Overview
Table 74. Sinopharm A-Think Pharmaceuticals Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 75. Sinopharm A-Think Pharmaceuticals Octreotide Product Offerings
Table 76. Sinopharm A-Think Pharmaceuticals Recent Development
Table 77. Sihuan Pharmaceutical Holdings Group Company Information
Table 78. Sihuan Pharmaceutical Holdings Group Introduction and Business Overview
Table 79. Sihuan Pharmaceutical Holdings Group Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 80. Sihuan Pharmaceutical Holdings Group Octreotide Product Offerings
Table 81. Sihuan Pharmaceutical Holdings Group Recent Development
Table 82. Shanghai Soho-Yiming Pharmaceuticals Company Information
Table 83. Shanghai Soho-Yiming Pharmaceuticals Introduction and Business Overview
Table 84. Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 85. Shanghai Soho-Yiming Pharmaceuticals Octreotide Product Offerings
Table 86. Shanghai Soho-Yiming Pharmaceuticals Recent Development
Table 87. Yibin Pharmaceutical Company Information
Table 88. Yibin Pharmaceutical Introduction and Business Overview
Table 89. Yibin Pharmaceutical Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 90. Yibin Pharmaceutical Octreotide Product Offerings
Table 91. Yibin Pharmaceutical Recent Development
Table 92. Key Raw Materials Lists
Table 93. Raw Materials Key Suppliers Lists
Table 94. Octreotide Downstream Customers
Table 95. Octreotide Distributors List
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Octreotide Product Picture
Figure 2. Global Octreotide Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Octreotide Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Octreotide Sales Volume (2020-2031) & (Gram)
Figure 5. Global Octreotide Sales Price (2020-2031) & (USD/Gram)
Figure 6. Octreotide Report Years Considered
Figure 7. Global Octreotide Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Octreotide Players Sales Volume Ranking (2024) & (Gram)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Octreotide Revenue in 2024
Figure 10. Octreotide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Octreotide Injection Picture
Figure 12. Octreotide Powder Picture
Figure 13. Octreotide Microspheres Picture
Figure 14. Global Octreotide Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 15. Global Octreotide Sales Value Market Share by Type, 2024 & 2031
Figure 16. Global Octreotide Sales Volume by Type (2020 VS 2024 VS 2031) & (Gram)
Figure 17. Global Octreotide Sales Volume Market Share by Type, 2024 & 2031
Figure 18. Global Octreotide Price by Type (2020-2031) & (USD/Gram)
Figure 19. Product Picture of Treating Severe Diarrhea
Figure 20. Product Picture of Treating Acromegaly
Figure 21. Product Picture of Others
Figure 22. Global Octreotide Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 23. Global Octreotide Sales Value Market Share by Application, 2024 & 2031
Figure 24. Global Octreotide Sales Volume by Application (2020 VS 2024 VS 2031) & (Gram)
Figure 25. Global Octreotide Sales Volume Market Share by Application, 2024 & 2031
Figure 26. Global Octreotide Price by Application (2020-2031) & (USD/Gram)
Figure 27. North America Octreotide Sales Value (2020-2031) & (US$ Million)
Figure 28. North America Octreotide Sales Value by Country (%), 2024 VS 2031
Figure 29. Europe Octreotide Sales Value, (2020-2031) & (US$ Million)
Figure 30. Europe Octreotide Sales Value by Country (%), 2024 VS 2031
Figure 31. Asia Pacific Octreotide Sales Value, (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Octreotide Sales Value by Region (%), 2024 VS 2031
Figure 33. South America Octreotide Sales Value, (2020-2031) & (US$ Million)
Figure 34. South America Octreotide Sales Value by Country (%), 2024 VS 2031
Figure 35. Middle East & Africa Octreotide Sales Value, (2020-2031) & (US$ Million)
Figure 36. Middle East & Africa Octreotide Sales Value by Country (%), 2024 VS 2031
Figure 37. Key Countries/Regions Octreotide Sales Value (%), (2020-2031)
Figure 38. Key Countries/Regions Octreotide Sales Volume (%), (2020-2031)
Figure 39. United States Octreotide Sales Value, (2020-2031) & (US$ Million)
Figure 40. United States Octreotide Sales Value by Type (%), 2024 VS 2031
Figure 41. United States Octreotide Sales Value by Application (%), 2024 VS 2031
Figure 42. Europe Octreotide Sales Value, (2020-2031) & (US$ Million)
Figure 43. Europe Octreotide Sales Value by Type (%), 2024 VS 2031
Figure 44. Europe Octreotide Sales Value by Application (%), 2024 VS 2031
Figure 45. China Octreotide Sales Value, (2020-2031) & (US$ Million)
Figure 46. China Octreotide Sales Value by Type (%), 2024 VS 2031
Figure 47. China Octreotide Sales Value by Application (%), 2024 VS 2031
Figure 48. Japan Octreotide Sales Value, (2020-2031) & (US$ Million)
Figure 49. Japan Octreotide Sales Value by Type (%), 2024 VS 2031
Figure 50. Japan Octreotide Sales Value by Application (%), 2024 VS 2031
Figure 51. South Korea Octreotide Sales Value, (2020-2031) & (US$ Million)
Figure 52. South Korea Octreotide Sales Value by Type (%), 2024 VS 2031
Figure 53. South Korea Octreotide Sales Value by Application (%), 2024 VS 2031
Figure 54. Southeast Asia Octreotide Sales Value, (2020-2031) & (US$ Million)
Figure 55. Southeast Asia Octreotide Sales Value by Type (%), 2024 VS 2031
Figure 56. Southeast Asia Octreotide Sales Value by Application (%), 2024 VS 2031
Figure 57. India Octreotide Sales Value, (2020-2031) & (US$ Million)
Figure 58. India Octreotide Sales Value by Type (%), 2024 VS 2031
Figure 59. India Octreotide Sales Value by Application (%), 2024 VS 2031
Figure 60. Octreotide Industrial Chain
Figure 61. Octreotide Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Octreotide in 2031?
The global market size of Octreotide in 2031 was 2.3 Million USD.
Which companies rank high in the global Octreotide market?
Which region is expected to have the highest market share?
What was the global market size of Octreotide in 2025?
What is the annual compound growth rate of the global Octreotide market size from 2025 to 2031?
Related Reports
Global Octreotide Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Octreotide market size was US$ 2.77 million in 2025 and is forecast to reach a readjusted size of US$ 2.27 million by 2032 with a CAGR of -2.8% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 78
USD 4250.00
(Single User License)
Global Octreotide Market Research Report 2026
The global Octreotide market was valued at US$ 2.77 million in 2025 and is anticipated to reach US$ 2.27 million by 2032, at a CAGR of -2.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 109
USD 2900.00
(Single User License)
Octreotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Octreotide was estimated to be worth US$ 2.77 million in 2025 and is projected to reach US$ 2.27 million, growing at a CAGR of -2.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 107
USD 3950.00
(Single User License)
Global Octreotide Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Octreotide market is projected to grow from US$ 2.8 million in 2024 to US$ 2.3 million by 2031, at a CAGR of -2.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 132
USD 4900.00
(Single User License)
Global Octreotide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Octreotide was estimated to be worth US$ 2.8 million and is forecast to reach approximately US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 137
USD 5900.00
(Single User License)
Global Octreotide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Octreotide market size was US$ 2.8 million in 2024 and is forecast to a readjusted size of US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 80
USD 4250.00
(Single User License)
Global Octreotide Market Research Report 2025
The global market for Octreotide was valued at US$ 2.8 million in the year 2024 and is projected to reach a revised size of US$ 2.3 million by 2031, growing at a CAGR of -2.8% during the forecast period.
Published Date: 2025-01-16
Pages: 78
USD 2900.00
(Single User License)
Global Octreotide Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published Date: 2024-04-17
Pages: 141
USD 5600.00
(Single User License)
Global Octreotide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published Date: 2024-04-16
Pages: 126
USD 5900.00
(Single User License)
Global Octreotide Market Insights, Forecast to 2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published Date: 2024-04-07
Pages: 96
USD 4900.00
(Single User License)
Global Octreotide Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Octreotide market size was US$ 2.77 million in 2025 and is forecast to reach a readjusted size of US$ 2.27 million by 2032 with a CAGR of -2.8% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 78
USD 4250.00 (Single User License)Global Octreotide Market Research Report 2026
The global Octreotide market was valued at US$ 2.77 million in 2025 and is anticipated to reach US$ 2.27 million by 2032, at a CAGR of -2.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 109
USD 2900.00 (Single User License)Octreotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Octreotide was estimated to be worth US$ 2.77 million in 2025 and is projected to reach US$ 2.27 million, growing at a CAGR of -2.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 107
USD 3950.00 (Single User License)Global Octreotide Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Octreotide market is projected to grow from US$ 2.8 million in 2024 to US$ 2.3 million by 2031, at a CAGR of -2.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 132
USD 4900.00 (Single User License)Global Octreotide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Octreotide was estimated to be worth US$ 2.8 million and is forecast to reach approximately US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 137
USD 5900.00 (Single User License)Global Octreotide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Octreotide market size was US$ 2.8 million in 2024 and is forecast to a readjusted size of US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 80
USD 4250.00 (Single User License)Global Octreotide Market Research Report 2025
The global market for Octreotide was valued at US$ 2.8 million in the year 2024 and is projected to reach a revised size of US$ 2.3 million by 2031, growing at a CAGR of -2.8% during the forecast period.
Published: 2025-01-16
Pages: 78
USD 2900.00 (Single User License)Global Octreotide Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published: 2024-04-17
Pages: 141
USD 5600.00 (Single User License)Global Octreotide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published: 2024-04-16
Pages: 126
USD 5900.00 (Single User License)Global Octreotide Market Insights, Forecast to 2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published: 2024-04-07
Pages: 96
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now